Trials / Terminated
TerminatedNCT02292823
MGuard™ Prime Embolic Protection Stent in Patients With Acute ST Elevation Myocardial Infarction
e-MASTER Registry: MGuard™ Prime Embolic Protection Stent in Patients With Acute ST Elevation Myocardial Infarction
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 63 (actual)
- Sponsor
- InspireMD · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Prospective, non-randomized, single arm, multicenter observational study. The objective is to evaluate the safety and efficacy of the MGuard™ Prime stent in the treatment of de novo stenotic lesions in coronary arteries in patients undergoing primary percutaneous coronary intervention (PCI) due to acute ST elevation myocardial infarction (STEMI) in a real-world setting.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | MGuard™ Prime Embolic Protection Stent System |
Timeline
- Start date
- 2014-04-01
- Primary completion
- 2015-09-01
- Completion
- 2016-09-01
- First posted
- 2014-11-17
- Last updated
- 2015-09-02
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT02292823. Inclusion in this directory is not an endorsement.